Corcept Therapeutics
CORT
CORT
205 hedge funds and large institutions have $1.08B invested in Corcept Therapeutics in 2019 Q4 according to their latest regulatory filings, with 35 funds opening new positions, 70 increasing their positions, 66 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
6% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 66
10% less capital invested
Capital invested by funds: $1.2B → $1.08B (-$126M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
205
Holding in Top 10
1
Calls
$10.2M
Puts
$5.98M
Top Buyers
| 1 | +$17.1M | |
| 2 | +$15.1M | |
| 3 | +$7.61M | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$7.2M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$6.47M |
Top Sellers
| 1 | -$11M | |
| 2 | -$8.44M | |
| 3 | -$4.44M | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$3.33M |
| 5 |
Millennium Management
New York
|
-$2.96M |